PIP-ENALAPRIL enalapril maleate 5mg tablet blister pack

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Javno poročilo o oceni Javno poročilo o oceni (PAR)
28-11-2017

Aktivna sestavina:

enalapril maleate, Quantity: 5 mg

Dostopno od:

GM Pharma International Pty Ltd

INN (mednarodno ime):

enalapril maleate

Farmacevtska oblika:

Tablet

Sestava:

Excipient Ingredients: lactose monohydrate; hypromellose; maleic acid; croscarmellose sodium; sodium stearylfumarate

Pot uporabe:

Oral

Enote v paketu:

30

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

HYPERTENSION ,Enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,CONGESTIVE HEART FAILURE ,Enalapril is indicated for the treatment of all degrees of symptomatic heart failure. In such patients, it is recommended that Enalapril be administered together with a diuretic. ,LEFT VENTRICULAR DYSFUNCTION ,All degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Povzetek izdelek:

Visual Identification: White to off white, round, flat faced, beveled edge tablets with breakline on one side and "5" debossed on the other side.; Container Type: Carton; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Licence status A

Datum dovoljenje:

2013-05-28